VIR-7831 Supply Agreement for Pandemic Purposes
What the buyer wrote
The evolution of the UK’s pandemic response has highlighted the critical importance and economic value of a multi-layered and comprehensive approach to COVID-19.The need for antibodies and other therapeutics has always been under consideration, the mutation of the virus and the risk this poses on antibody and vaccine efficacy has only recently been properly identified and still requires further academic studies.These unforeseen circumstances mean there is now a critical, urgent need to procure and deploy a new class of mAbs, that can neutralise any COVID-19 variant. These neutralising mAbs provide protection to a cohort of the population who, for medical reasons, cannot mount an appropriate …
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- VIR-7831 Supply Agreement for Pandemic Purposes
- How they are buying
- Given to one supplier, no competitionNobody else was asked, and the buyer has to be able to justify that.
- Type
- goods
- Kind of work
- Pharmacy and medicines
Who the buyer named
Zak Durrani was the named contact on this notice.